Facebook Pixel
 

S6 E9: Interview with Dr Stephen Bradley on CXR rates in GP & lung cancer; orthostatic HYPERtension; overactive bladder tests

NO
PHARMACEUTICAL INFLUENCE
NO PHARMACEUTICAL INFLUENCE
11th April 2025

If you are having difficulties listening to this Podcast, try to play this episode in Spotify

Welcome to the Hot Topics podcast from NB Medical with Dr Neal Tucker. In this episode, we are joined by Dr Stephen Bradley, lead author of a new paper published in the BJGP looking at rates of CXR use in general practice and how this influences lung cancer stage at diagnosis and mortality

He discusses the findings of his research and how this might influence our practice. 

In other research, we look at a new paper in the BMJ on orthostatic HYPERtension - yes, you read that correctly - does treatment help, and does it really matter in the first place? And from the Lancet, research looking at the role of urodynamic studies in women with refractory overactive bladder - does it improve outcomes, or should it be stopped?

References

BMJ Orthostatic hypertension and BP treatment

BMJ OH editorial

Lancet Refractory overactive bladder & urodynamic studies

BJGP CXR in GP & lung cancer staging and mortality


Join us at one of our upcoming courses or live webinars